Global Nanoparticle Drug Delivery Systems Market Size Share, Growth and Trends Report Segmented by Type (LNP, Polymeric, Inorganic), Modality (Small Molecule, Biologics, CGT), Application (Oncology, CVDs), End-user Analysis, & Regional Forecast to 2031

1. Introduction
   • Introduction​
   • Market Scope​
     • Market Definition​
     • Segments Covered​
     • Regional Segmentation​
   • Research Timeframe​
   • Currency Considered​
   • Study Limitations​
   • Stakeholders​
   • List of Abbreviations​
   • Key Conferences and Events (2026-2027)​
2. Research Methodology​
   • Secondary Research​
   • Primary Research​
   • Market Estimation​
     • Bottom-Up Approach​
     • Top-Down Approach​
   • Market Forecasting​
3. Executive Summary
   • Nanoparticle Drug Delivery Systems Market Snapshot (2026-2031)​
   • Segment Overview​
   • Regional Snapshot​
   • Competitive Insights ​

4. Market Overview
   • Market Dynamics
     • Drivers
       • Growing demand for targeted drug delivery
       • Rising burden of chronic diseases
       • Expansion of RNA therapeutics and gene therapy
       • Advances in nanotechnology and materials science
       • Growth of precision medicine
       • Ability to cross biological barriers
     • Restraints​
       • High development and manufacturing costs
       • Regulatory complexity
       • Reimbursement and cost-effectiveness concerns
       • Limited clinical translation
     • Opportunities​
       • Expansion beyond oncology applications
       • Growth of gene editing and nucleic acid therapies
       • Emerging market expansion
       • Increasing adoption of combination therapies
       • Advancements in brain drug delivery  
     • Key Market Trends
       • Lipid nanoparticles becoming the leading delivery platform
       • Development of targeted and ligand-functionalized nanoparticles
       • Emergence of stimuli-responsive smart nanoparticles
       • Integration with cell and gene therapies
     • Unmet Market Needs​
     • Industry Speaks​

5. Global Nanoparticle Drug Delivery Systems Market Size & Forecast (2024-2031), By Type, USD Billion
   • Introduction​
   • Lipid Nanoparticles (LNPs)
   • Polymeric Nanoparticles
   • Inorganic Nanoparticles
   • Protein-based Nanoparticles
   • Other Types
6. Global Nanoparticle Drug Delivery Systems Market Size & Forecast (2024-2031), By Modality, USD Billion
   • Introduction​
   • Small Molecule Drugs
   • Biologics
   • Nucleic Acid Therapeutics
   • Cell and Gene Therapies (CGT)
   • Other Modalities
7. Global Nanoparticle Drug Delivery Systems Market Size & Forecast (2024-2031), By Application, USD Billion​
   • Introduction​
   • Oncology
   • Infectious Diseases
   • Neurological Disorders
   • Cardiovascular Diseases (CVDs)
   • Autoimmune & Inflammatory Diseases
   • Other Applications
8. Global Nanoparticle Drug Delivery Systems Market Size & Forecast (2024-2031), By End User, USD Billion​
   • Introduction​
   • Hospitals & Clinics
   • Pharmaceutical & Biotechnology Companies
   • Research & Academic Institutes
   • Other End Users
9. Global Nanoparticle Drug Delivery Systems Market Size & Forecast (2024-2031), By Region, USD Billion
   • Introduction​
   • North America Nanoparticle Drug Delivery Systems Market Size & Forecast (2024-2031), By Country, USD Billion​
     • US​
       • Market Size & Forecast, By Type, (USD Billion)​
       • Market Size & Forecast, By Modality (USD Billion)​
       • ​Market Size & Forecast, By Application (USD Billion)​
       • Market Size & Forecast, By End User (USD Billion)​
     • Canada​
       • Market Size & Forecast, By Type, (USD Billion)​
       • Market Size & Forecast, By Modality (USD Billion)​
       • ​Market Size & Forecast, By Application (USD Billion)​
       • Market Size & Forecast, By End User (USD Billion)​
   • Europe Nanoparticle Drug Delivery Systems Market Size & Forecast (2024-2031), By Country, USD Billion​
     • UK ​
       • Market Size & Forecast, By Type, (USD Billion)​
       • Market Size & Forecast, By Modality (USD Billion)​
       • ​Market Size & Forecast, By Application (USD Billion)​
       • Market Size & Forecast, By End User (USD Billion)​
     • Germany ​
       • Market Size & Forecast, By Type, (USD Billion)​
       • Market Size & Forecast, By Modality (USD Billion)​
       • ​Market Size & Forecast, By Application (USD Billion)​
       • Market Size & Forecast, By End User (USD Billion)​​
     • France ​
       • Market Size & Forecast, By Type, (USD Billion)
       • Market Size & Forecast, By Modality (USD Billion)
       • Market Size & Forecast, By Application (USD Billion)
       • Market Size & Forecast, By End User (USD Billion)
     • Italy ​
       • Market Size & Forecast, By Type, (USD Billion)
       • Market Size & Forecast, By Modality (USD Billion)
       • Market Size & Forecast, By Application (USD Billion)
       • Market Size & Forecast, By End User (USD Billion)
     • Spain ​
       • Market Size & Forecast, By Type, (USD Billion)
       • Market Size & Forecast, By Modality (USD Billion)
       • Market Size & Forecast, By Application (USD Billion)
       • Market Size & Forecast, By End User (USD Billion)
     • Rest of Europe ​
       • Market Size & Forecast, By Type, (USD Billion)
       • Market Size & Forecast, By Modality (USD Billion)
       • Market Size & Forecast, By Application (USD Billion)
       • Market Size & Forecast, By End User (USD Billion)
   • Asia Pacific (APAC) Nanoparticle Drug Delivery Systems Market Size & Forecast (2024-2031), By Country, USD Billion​
     • China ​
       • Market Size & Forecast, By Type, (USD Billion)
       • Market Size & Forecast, By Modality (USD Billion)
       • Market Size & Forecast, By Application (USD Billion)
       • Market Size & Forecast, By End User (USD Billion)
     • Japan ​
       • Market Size & Forecast, By Type, (USD Billion)
       • Market Size & Forecast, By Modality (USD Billion)
       • Market Size & Forecast, By Application (USD Billion)
       • Market Size & Forecast, By End User (USD Billion)
     • India ​
       • Market Size & Forecast, By Type, (USD Billion)
       • Market Size & Forecast, By Modality (USD Billion)
       • Market Size & Forecast, By Application (USD Billion)
       • Market Size & Forecast, By End User (USD Billion)
     • Rest of Asia Pacific ​
       • Market Size & Forecast, By Type, (USD Billion)
       • Market Size & Forecast, By Modality (USD Billion)
       • Market Size & Forecast, By Application (USD Billion)
       • Market Size & Forecast, By End User (USD Billion)
   • Latin America (LATAM) Nanoparticle Drug Delivery Systems Market Size & Forecast (2024-2031), USD Billion​
     • Market Size & Forecast, By Type, (USD Billion)
     • Market Size & Forecast, By Modality (USD Billion)
     • Market Size & Forecast, By Application (USD Billion)
     • Market Size & Forecast, By End User (USD Billion)
   • Middle East & Africa (MEA) Nanoparticle Drug Delivery Systems Market Size & Forecast (2024-2031), USD Billion​
     • Market Size & Forecast, By Type, (USD Billion)
     • Market Size & Forecast, By Modality (USD Billion)
     • Market Size & Forecast, By Application (USD Billion)
     • Market Size & Forecast, By End User (USD Billion)

10. Competitive Landscape
    • Key Players and their Competitive Positioning
      • Key Player Comparison
      • Segment-wise Player Mapping
      • Market Share Analysis (2025)
      • Company Categorization Matrix
        • Dominants/Leaders
        • New Entrants
        • Emerging Players
        • Innovative Players
    • Key Strategies Assessment, By Player (2023-2026)
      • New Product Launch
      • Partnerships, Agreements, & Collaborations
      • Mergers & Acquisitions
      • Geographic Expansion

11. Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

• Pfizer Inc.
• Moderna, Inc.
• BioNTech SE
• Alnylam Pharmaceuticals, Inc.
• Arbutus Biopharma Corporation
• AstraZeneca PLC
• Johnson & Johnson
• Merck & Co., Inc.
• AbbVie Inc.
• Cytiva
• Other Prominent Players

Note: *Indicative list

**For listed companies